Next Article in Journal
GPR68: An Emerging Drug Target in Cancer
Next Article in Special Issue
Recent Developments in Metal-Based Drugs and Chelating Agents for Neurodegenerative Diseases Treatments
Previous Article in Journal
Mechanisms Underlying the Visual Benefit of Cell Transplantation for the Treatment of Retinal Degenerations
Review

Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?

by 1, 2, 3,* and 1,*
1
Department of Biochemistry, Medical College, Qingdao University, Qingdao 266071, China
2
Beijing Institute for Brain Disorders, Capital Medical University, Beijing 100069, China
3
The Brain Science Center, Beijing Institute of Basic Medical Sciences, 100850 Beijing, China
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(3), 558; https://doi.org/10.3390/ijms20030558
Received: 27 December 2018 / Revised: 9 January 2019 / Accepted: 13 January 2019 / Published: 28 January 2019
Alzheimer’s disease (AD) is one of the most common causes of dementia. Its pathogenesis is characterized by the aggregation of the amyloid-β (Aβ) protein in senile plaques and the hyperphosphorylated tau protein in neurofibrillary tangles in the brain. Current medications for AD can provide temporary help with the memory symptoms and other cognitive changes of patients, however, they are not able to stop or reverse the progression of AD. New medication discovery and the development of a cure for AD is urgently in need. In this review, we summarized drugs for AD treatments and their recent updates, and discussed the potential of microglia induced neuroinflammation as a target for anti-AD drug development. View Full-Text
Keywords: Alzheimer’s disease; neuroinflammation; microglia; drug development Alzheimer’s disease; neuroinflammation; microglia; drug development
Show Figures

Figure 1

MDPI and ACS Style

Dong, Y.; Li, X.; Cheng, J.; Hou, L. Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target? Int. J. Mol. Sci. 2019, 20, 558. https://doi.org/10.3390/ijms20030558

AMA Style

Dong Y, Li X, Cheng J, Hou L. Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target? International Journal of Molecular Sciences. 2019; 20(3):558. https://doi.org/10.3390/ijms20030558

Chicago/Turabian Style

Dong, Yuan; Li, Xiaoheng; Cheng, Jinbo; Hou, Lin. 2019. "Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?" Int. J. Mol. Sci. 20, no. 3: 558. https://doi.org/10.3390/ijms20030558

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop